Alan Jones
Internal Medicine · Vancouver, WANPI 1982640710
Payments from drug & device makers
Across 321 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$975
- Lilly USA, LLC$601
- Amgen$579
- Novo Nordisk$515
- Pfizer$449
- AstraZeneca$417
- plus $2K from 35 others
What the payments were for
- Food & beverage$5,995100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $975 |
| Lilly USA, LLC | 31 | $601 |
| Amgen | 26 | $579 |
| Novo Nordisk | 27 | $515 |
| Pfizer | 25 | $449 |
| AstraZeneca | 26 | $417 |
| E.r. Squibb & Sons, L.L.C. | 24 | $384 |
| Johnson & Johnson | 17 | $331 |
| GSK | 11 | $201 |
| Boehringer Ingelheim | 8 | $147 |
| Novartis | 6 | $121 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $117 |
| Astellas Pharma US Inc | 6 | $117 |
| Sanofi-aventis U.S. LLC | 4 | $77 |
| Exact Sciences | 3 | $75 |
| Abbott | 3 | $71 |
| Merck | 5 | $64 |
| Boston Scientific | 4 | $63 |
| Gilead | 3 | $60 |
| CMP Pharma, Inc. | 3 | $59 |
| Bayer | 4 | $59 |
| Medtronic | 1 | $56 |
| Sanofi Pasteur Inc. | 3 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $45 |
| Bausch Health US, LLC | 2 | $43 |
| Biohaven Pharmaceuticals, Inc. | 3 | $39 |
| Amarin Pharma, Inc. | 2 | $29 |
| Radius Health, Inc. | 2 | $28 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| GRT US Holding, Inc. | 2 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Lucid Diagnostics Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Seqirus USA Inc | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Circassia Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Corcept Therapeutics | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Humira$103
How this compares
$6,003 in reported general payments places this provider in the 95th percentile of 2,038 internal medicine providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $23,280 |
| Tamsulosin Hcl | 24 | $550 |
| Rosuvastatin Calcium | 24 | $511 |
| Valsartan | 18 | $497 |
| Levothyroxine Sodium | 29 | $425 |
| Pravastatin Sodium | 22 | $413 |
| Atorvastatin Calcium | 37 | $392 |
| Simvastatin | 39 | $350 |
| Amlodipine Besylate | 35 | $324 |
| Lisinopril | 32 | $319 |
| Potassium Chloride | 13 | $262 |
| Metoprolol Succinate | 12 | $213 |
| Montelukast Sodium | 13 | $188 |
| Pantoprazole Sodium | 14 | $181 |
| Hydrochlorothiazide | 30 | $169 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $449 | $23,28016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,038 internal medicine providers in Washington.
Other internal medicine in Vancouver
- Sabrina BenjaminOlympia$7.9M
- Ryan AhernSeattle$7.3M
- Eric KleinOlympia$2.4M
- Scott RamseySeattle$2M
- Vidya MenonTacoma$1.8M
- Peter ShalitSeattle$1.8M
- Yuan Po TuEverett$1.6M
- Peiqing QianSeattle$1.5M
- Radica AlicicSpokane$1.5M
- Shelly KhuranaLynnwood$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.